| Synonyms: | |
| Status: | Approved (2000) |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| ATC: | L02AE04 |
| UNII: | 9081Y98W2V |
| InChI Key | VXKHXGOKWPXYNA-PGBVPBMZSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C64H82N18O13 |
| Molecular Weight | 1311.47 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Infertility | 3 | D007246 | ClinicalTrials |
| Endometriosis | 3 | D004715 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Ovarian Hyperstimulation Syndrome | 3 | D016471 | ClinicalTrials |
| Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
| Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 3 | D064129 | ClinicalTrials |
| Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
| Puberty, Precocious | 3 | D011629 | ClinicalTrials |
| Puberty, Precocious | 3 | D011629 | ClinicalTrials |
| HIV Infections | 2 | D015658 | ClinicalTrials |
| Salivary Gland Neoplasms | 2 | D012468 | ClinicalTrials |
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 63633 |
| ChEMBL | CHEMBL1201334 |
| DrugBank | DB06825 |
| DrugCentral | 2968 |
| FDA SRS | 9081Y98W2V |
| Guide to Pharmacology | 1177 |
| SureChEMBL | SCHEMBL5079698 |